When it comes to anxiety and depression, health care providers are often quick to prescribe a number of different anti-depressants. While this is the case, there are now other options such as CBD Anxiety Wellbeing. While some anti-depressants have proven successful, others often need to replaced over the course of treatment.
CBD was originally discovered in 1940 in what is known as the hemp or cannabis plant. CBD is one of a number of cannabinoids found in the plant. In addition, the oil accounts for more than forty percent of the plant's extract. To date, studies have been completed on CBD in relation to anxiety, pain, movement disorders and epilepsy.
CBD oil can be ingested in different forms. These include vapor, smoke, drinks and edibles such as chocolate cover coffee beans, honey sticks, peanut better, cough drops and gummies. In addition, there are now CBD dog treats for treating dogs with anxiety or hyperactivity issues. Whereas, raw coffee beans can also be purchased with which to make CBD infused coffee.
CBD is currently available with or without traces of THC. For, one version contains CBD as the active ingredient with no trace of THC. Whereas, the other version contains trace amounts of THC while CBD remains the active ingredient.
While the drug Epidiolex which contains CBD oil has received a green light for marketing from the United States FDA, there remains some confusion as to the full legality of CBD products. In addition, there can be minimal side effects depending on the length of use and potency of the product. While these can include a loss of appetite, diarrhea, fatigue, malaise, weakness and sleeping problems, these are minimal compared to side-effects associated with medications which contain opioids.
Currently, the United States FDA has labeled Epidiolex as a Schedule V drug. While non-Epidiolex CBD still remains a Schedule I drug prohibited for use in many areas. Regardless, stores across the United States are now selling CBD oil and products on the open market. Whereas, the United Nations has not scheduled CBD under any drug control treaties and World Health Organization officials have recommended that the drug remain unclassified or scheduled.
While there are few side effects compared to opioids and other narcotics, the potential of interactions with pharmaceuticals or over the counter drugs remain widely unknown. While this is the case, it is suspected that due to the potency of the extract, it could slow down the process of other medications. As far as dangerous interactions, at this point and time, none have been reported through research studies or use of CBD products.
As with medical marijuana and THC, the prescription forms of CBD extract are stronger than that of over the counter products. One such drug, Nabiximols combines THC and CBD in equal proportion. The drug, approved by Health Canada in 2005 was developed for the treatment of pain related to MS. Whereas, in 2007, the drug also became available to cancer patients as an ongoing treatment for pain and side-effects from chemotherapy and radiation, such as nausea.
CBD was originally discovered in 1940 in what is known as the hemp or cannabis plant. CBD is one of a number of cannabinoids found in the plant. In addition, the oil accounts for more than forty percent of the plant's extract. To date, studies have been completed on CBD in relation to anxiety, pain, movement disorders and epilepsy.
CBD oil can be ingested in different forms. These include vapor, smoke, drinks and edibles such as chocolate cover coffee beans, honey sticks, peanut better, cough drops and gummies. In addition, there are now CBD dog treats for treating dogs with anxiety or hyperactivity issues. Whereas, raw coffee beans can also be purchased with which to make CBD infused coffee.
CBD is currently available with or without traces of THC. For, one version contains CBD as the active ingredient with no trace of THC. Whereas, the other version contains trace amounts of THC while CBD remains the active ingredient.
While the drug Epidiolex which contains CBD oil has received a green light for marketing from the United States FDA, there remains some confusion as to the full legality of CBD products. In addition, there can be minimal side effects depending on the length of use and potency of the product. While these can include a loss of appetite, diarrhea, fatigue, malaise, weakness and sleeping problems, these are minimal compared to side-effects associated with medications which contain opioids.
Currently, the United States FDA has labeled Epidiolex as a Schedule V drug. While non-Epidiolex CBD still remains a Schedule I drug prohibited for use in many areas. Regardless, stores across the United States are now selling CBD oil and products on the open market. Whereas, the United Nations has not scheduled CBD under any drug control treaties and World Health Organization officials have recommended that the drug remain unclassified or scheduled.
While there are few side effects compared to opioids and other narcotics, the potential of interactions with pharmaceuticals or over the counter drugs remain widely unknown. While this is the case, it is suspected that due to the potency of the extract, it could slow down the process of other medications. As far as dangerous interactions, at this point and time, none have been reported through research studies or use of CBD products.
As with medical marijuana and THC, the prescription forms of CBD extract are stronger than that of over the counter products. One such drug, Nabiximols combines THC and CBD in equal proportion. The drug, approved by Health Canada in 2005 was developed for the treatment of pain related to MS. Whereas, in 2007, the drug also became available to cancer patients as an ongoing treatment for pain and side-effects from chemotherapy and radiation, such as nausea.
About the Author:
Our alternative health blog reveals how CBD anxiety wellbeing can make a difference to your life. Read the newly published articles online at http://www.thebotanicalwonders.com.
No comments:
Post a Comment